gdc-0973 and Iris-Neoplasms

gdc-0973 has been researched along with Iris-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for gdc-0973 and Iris-Neoplasms

ArticleYear
Regression of Iris Metastasis After Systemic Treatment With Melanoma-Targeted Therapy.
    JAMA ophthalmology, 2017, Feb-09, Volume: 135, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Humans; Iris Neoplasms; Male; Melanoma; Piperidines; Protein Kinase Inhibitors; Remission Induction; Skin Neoplasms; Vemurafenib

2017